The FDA has approved Differin (adapalene, from Galderma) gel, 0.3%, a higher concentration formulation of Differin (adapalene) 0.1%, a topical retinoid indicated for the treatment of acne. It is expected to be available by prescription July 2007.

For more information call (866) 735-4137 or visit www.differin.com.